Jasper Therapeutics, Inc. confidential investors investigation image
Image for illustration purpose only - Photo by Angelo_Giordano on Pixabay

Jasper Therapeutics, Inc. (JSPR)

  • Investigation
Contact a Law Firm
Investigation
05/22/2023
Initial Lawsuit
To be active

Investigation

This is a confidential investigation of certain directors & officers of Jasper Therapeutics, Inc. (JSPR) regarding a potential breach of fiduciary duties to the company and its shareholders.

Jasper Therapeutics, Inc. (JSPR) investors and shareholders are invited to contact the law firm below for additional information.

Brios is not a law firm and does not make any representation or judgment as to the qualifications, expertise, or credentials of any law firm advertising on our website, please refer to our terms and conditions for further information.
  • Investigation Date
    05/22/2023
  • Hypothetical Affected Period
    January 1, 2022 to April 14, 2023
  • Hypothetical Transgression
    Breach of Fiduciary Duty
Main Event

Annual Proxy

04/21/2023

SEC Filing

Jasper Therapeutics, Inc. files its proxy statement with the SEC for its 2023 annual meeting to be held on Thursday, June 7, 2023.

The stock impact compares the closing price immediately preceding the date of the event and the following closing price. The price difference also reflects the overall mix of information.

Stock Impact

Close Previous close Price variation Percentage variation
$1.37 $1.38 $-0.01 -0.72%
See more on Factual Timeline

Initial Lawsuit

No lawsuit has been filed in connection with this investigation. Contact a Law Firm regarding the filing of a complaint.

Please contact the following law firm for additional information

Fields Kupka & Shukurov LLP

Contact
Profile

Attorney advertising.

Factual Timeline

More

More Cases & Investigations